Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 1764-1768, June 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hunt, S. M.
Right arrow Articles by Rivlin, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hunt, S. M.
Right arrow Articles by Rivlin, R. S.

Thyroid Hormone Regulation of Mitochondrial {alpha}-Glycerophosphate Dehydrogenase in Liver and Hepatoma1

Sara M. Hunt2, Martha Osnos and Richard S. Rivlin

Department of Medicine and Institute of Cancer Research, Francis Delafield Hospital, College of Physicians and Surgeons of Columbia University, New York, New York 10032

The effect of thyroid hormone in rats upon the induction of mitochondrial {alpha}-glycerophosphate dehydrogenase (LM-GPDH) has been studied in normal liver, in Novikoff hepatoma, in Morris hepatoma 7800, and in host liver of animals bearing Novikoff or Morris hepatomas. Enzyme activities were determined both before and 48 hr after a single i.p. injection of L-triiodothyronine (T3), 100 µg/100 g body weight. In livers of rats bearing the rapidly growing Novikoff hepatoma, basal enzyme activity is increased 75% over levels in nontumor-bearing controls. By contrast, hepatic enzyme activity in rats bearing the more slowly growing Morris hepatoma does not differ from control levels. In normal animals, administration of T3 greatly increases activity of LM-GPDH. In livers of animals bearing either Novikoff or Morris hepatomas, enzyme activity after administration of T3 is similar to levels obtained in livers of normal animals similarly treated.

The activity of LM-GPDH in Novikoff hepatoma, expressed per mg mitochondrial protein, is considerably higher than in liver, and cannot be induced by T3. In the Morris hepatoma, basal activity is similar to that of normal liver, and is increased 2-fold by T3. The present study, therefore, indicates that induction of LM-GPDH by thyroid hormone is not demonstrable in the Novikoff hepatoma, is diminished but present in the Morris hepatoma 7800, and is unimpaired in liver of rats bearing either tumor.

1 This investigation was supported by USPHS Research Grant CA-02332 from the National Cancer Institute, NIH.

2 Supported in part by USPHS Training Grant CA-05011. Present address: University of Connecticut McCook Hospital, Hartford, Conn.

Received 11/10/69. Accepted 2/12/70.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.